Innocan Pharma INNPF Cash Flow Statement (2023-2025)

OTC INNPF
$1.29 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST
Reported Financials

Innocan Pharma Quarterly Cash Flow Statement

Periods 9 quarters
Latest Dec 2025

Innocan Pharma reported free cash flow of $0.01M for the quarter ended Dec 2025. This cash flow statement covers 9 quarters of results from Dec 2023 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income -1.45M0.96M0.28M-0.05M-0.23M-0.32M-1.65M1.86M
Depreciation and DepletionDep. & Depletion 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Share-based CompensationStock Comp. 1.16M0.38M0.22M0.25M0.10M0.02M1.60M-0.25M
Gains from Investment SecuritiesGains Investment -0.04M0.20M
Other non-cash itemsOther Non-Cash 0.04M0.07M-0.02M-2.26M-0.20M-0.05M-1.55M
Change in Working Capital
Change in InventoryChange Inventory -0.86M-0.06M-0.77M0.11M0.36M0.35M0.16M0.27M
Change in Account PayablesChange Payables 0.37M-0.09M-0.26M0.05M-0.01M0.06M-0.19M0.19M
Change in Other Operating AssetsOther Assets Change -0.54M0.97M-0.71M0.47M-0.57M0.31M-0.12M0.50M
Change in Other Operating LiabilitiesOther Liabilities Change -0.22M0.14M
Other Working Capital ChangesOther WC Changes 0.54M-0.97M0.71M-0.68M0.57M-0.31M0.12M-0.37M
Cash from OperationsCash from Ops. -0.75M0.68M-1.00M0.37M0.69M0.02M
Investing Activities
Capital ExpendituresCapex 0.00M0.00M-0.01M0.00M-0.01M0.00M0.00M-0.01M
Change in Property, Plant and EquipmentChange in PP&E 0.00M0.00M0.01M0.00M0.01M0.00M0.00M0.01M
Cash from Investing ActivitiesCash from Investing 0.00M0.00M-0.01M0.00M0.00M0.00M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 0.64M
Net Long-Term Debt Issued (Repaid)Net LT Debt 0.64M
Net Debt Issuances and RepaymentsNet Debt Issuance 0.64M
Change in Capital Stock
Common Stock IssuedStock Issued 0.62M0.40M-0.12M
Net Shares Issued and RepurchasedNet Shares Issued 0.62M0.40M-0.12M
Net Equity Issued and RepurchasedNet Equity Issued 0.62M0.40M-0.12M
Dividend Payments
Dividends Paid - Common and PreferredDiv Paid (Total) -0.01M-0.01M-0.01M-0.01M0.00M0.00M0.00M
Cash from Financing ActivitiesCash from Financing 1.45M-0.01M0.86M1.00M0.15M0.00M
Additional items
Exchange Rate EffectFX Effect 0.01M-0.07M0.02M0.00M0.05M
Change in Cash 0.71M0.59M-0.13M1.36M0.89M0.02M
Ending Cash Balance 3.89M4.60M5.19M5.06M5.01M6.37M7.26M7.27M6.69M
Free Cash FlowFCF -0.75M0.68M-1.00M0.00M0.37M0.69M0.03M0.01M
Net Cash FlowNCF 0.70M0.67M-0.15M1.36M0.84M0.02M
Income Taxes PaidTaxes Paid -0.41M-0.51M

Innocan Pharma Cash Flow Statement API

Pull Innocan Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=INNPF&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY